EP Wealth Advisors LLC Sells 1,675 Shares of Humana Inc. (NYSE:HUM)

EP Wealth Advisors LLC lowered its position in shares of Humana Inc. (NYSE:HUM) by 72.5% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 636 shares of the insurance provider’s stock after selling 1,675 shares during the quarter. EP Wealth Advisors LLC’s holdings in Humana were worth $201,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of HUM. Wealth Enhancement Advisory Services LLC grew its position in Humana by 9.9% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 8,713 shares of the insurance provider’s stock worth $3,256,000 after buying an additional 787 shares in the last quarter. Envestnet Portfolio Solutions Inc. increased its position in shares of Humana by 14.4% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 5,490 shares of the insurance provider’s stock worth $2,051,000 after purchasing an additional 689 shares during the period. OFI Invest Asset Management raised its stake in Humana by 20.7% in the second quarter. OFI Invest Asset Management now owns 251 shares of the insurance provider’s stock valued at $88,000 after purchasing an additional 43 shares in the last quarter. Raymond James & Associates lifted its position in Humana by 5.2% during the second quarter. Raymond James & Associates now owns 96,189 shares of the insurance provider’s stock worth $35,941,000 after purchasing an additional 4,757 shares during the period. Finally, Nisa Investment Advisors LLC grew its stake in Humana by 5.8% during the second quarter. Nisa Investment Advisors LLC now owns 34,620 shares of the insurance provider’s stock worth $12,967,000 after buying an additional 1,903 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

HUM has been the subject of several analyst reports. Wells Fargo & Company dropped their target price on shares of Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a research report on Monday, November 4th. Piper Sandler downgraded shares of Humana from an “overweight” rating to a “neutral” rating and lowered their price objective for the company from $392.00 to $274.00 in a research report on Thursday, October 3rd. Deutsche Bank Aktiengesellschaft lowered their price target on Humana from $349.00 to $250.00 and set a “hold” rating for the company in a report on Thursday, October 3rd. Truist Financial lowered their target price on Humana from $400.00 to $260.00 and set a “hold” rating for the company in a research note on Friday, October 11th. Finally, Leerink Partnrs downgraded shares of Humana from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Twenty investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $304.15.

Humana Trading Up 0.5 %

NYSE:HUM opened at $274.12 on Friday. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $486.00. The firm’s fifty day moving average is $274.13 and its 200-day moving average is $324.53. The firm has a market cap of $33.01 billion, a P/E ratio of 24.28, a P/E/G ratio of 2.15 and a beta of 0.53. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. The firm had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. Equities analysts expect that Humana Inc. will post 16.14 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.29%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is presently 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.